No published human study tracks continuous use beyond 12 weeks, making extended unsupervised administration an undocumented risk with the current state of evidence on BPC-157
Failure to disclose relevant health information may affect your safety and treatment outcomes
Food and Drug Administration (FDA) hasnt approved any weight loss patches that work like the blockbuster injected GLP-1 drugs Ozempic, Wegovy, Zepbound, and Mounjaro, says Jody Dushay, MD, an assistant professor at Harvard Medical School and an endocrinologist at Beth Israel Deaconess Medical Center in Boston
In 2022, she developed the Integrative Residency Program, providing a virtual learning opportunity for other practitioners to enhance their knowledge in areas such as Thyroid Health, Hormone Optimization in Men and Women, Gut Health management, Peptide Therapy, and Aesthetic Medicine